621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
Main Authors: | Nan Zhang, Kevin Conlon, Donna Bernstein, Robert Somerville, Thomas Waldmann, Rosa Nguyen, Steven Highfill, Crystal L Mackall, David Stroncek, Sabina Kaczanowska, Julia Segal, Anh Dinh, Melinda S Merchant, Rosandra N Kaplan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1044 High dose of rhIL-10 enhances CD8 T cell and NK cell mediated tumor cell killing in vitro
by: Elli Narvi, et al.
Published: (2023-11-01) -
Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
by: Huan Wang, et al.
Published: (2021-03-01) -
Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research
by: Fa-Min Gong, et al.
Published: (2024-01-01) -
Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE
by: Lei Yu, et al.
Published: (2019-03-01) -
Pharmacokinetic Study of rhIL-18BP and Its Effect on Radiation-Induced Cytokine Changes in Mouse Serum and Intestine
by: Wanchang Cui, et al.
Published: (2022-12-01)